Your browser doesn't support javascript.
loading
Who and when should we screen for prostate cancer? Interviews with key opinion leaders.
Carlsson, Sigrid; Leapman, Michael; Carroll, Peter; Schröder, Fritz; Albertsen, Peter C; Ilic, Dragan; Barry, Michael; Frosch, Dominick L; Vickers, Andrew.
Afiliação
  • Carlsson S; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, 10017, NY, USA. carlssos@mskcc.org
  • Leapman M; Department of Urology, University of California, San Francisco, CA, USA. michael.leapman@ucsf.edu.
  • Carroll P; Department of Urology, University of California, San Francisco, CA, USA. peter.carroll@ucsf.edu.
  • Schröder F; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. secr.schroder@erasmusmc.nl.
  • Albertsen PC; University of Connecticut Health Center, 263 Farmington Avenue, Farmington, 06030, CT, USA. albertsen@uchc.edu.
  • Ilic D; Department of Epidemiology & Preventive Medicine, Monash University, Level 6, The Alfred Centre, 99 Commercial Rd, Melbourne, VIC, 3004, Australia. dragan.ilic@monash.edu.
  • Barry M; The Informed Medical Decisions Foundation, Boston, MA, USA. dominick.frosch@moore.org.
  • Frosch DL; Gordon and Betty Moore Foundation, Palo Alto, CA & Department of Medicine, University of California, Los Angeles, USA. mbarry@healthwise.org.
  • Vickers A; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, 10017, NY, USA. vickersa@mskcc.org.
BMC Med ; 13: 288, 2015 Nov 27.
Article em En | MEDLINE | ID: mdl-26612204
ABSTRACT
Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Diagnostic_studies / Qualitative_research / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Diagnostic_studies / Qualitative_research / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article